By 2033, the global sterilants market is expected to reach US$ 4244.1 million, surpassing US$ 2361.627 million in 2023. A CAGR of 6% indicates positive market growth over the forecast period.
Sterilization is one of the most important processes to be followed in industries and healthcare facilities. The rising incidence of infection transmission through surgical instruments or contaminated surface contact with the human skin surface or tissues has demanded effective and compatible sterilants or sporicidal agents in the sterilants market.
The growing demand for sterilized environments (in terms of sterilized surgical instruments and equipment) and surging demand for compatible sterilants have driven opportunities for manufacturers. Strategic acquisitions and collaborations by the manufacturers are leading to high growth of the sterilants market in the coming years. Also, the global pandemic has boosted the requirement for hygiene solutions, which amplifies the growth potential of the market.
The increasing demand for processed food, which uses sterilants as food preservatives to increase shelf life and protect them against microorganisms, is a major driver of the sterilant market. In addition, the growing healthcare industry contributes to the growth of the global sterilant market, since medical equipment needs to be sterilized with sterilants such as peracetic acid.
In the coming years, the global sterilant market is expected to grow due to the increasing use of sterilants in agriculture to protect crops. Furthermore, sterilants such as peracetic acid are environmentally friendly, making them preferred for sterilizing medical equipment; they also do not leave any toxic residue after application, making them an opportunistic market for the forecast period.
The application of sterilants to the body can, however, cause adverse health effects, such as irritation of the eyes, allergies, and respiratory irritation. The high concentration of some sterilants is corrosive in nature, resulting in the degradation of inanimate surfaces; as a result, the growth of the sterilants market is predicted to suffer during the forecast period.
| Attributes | Details |
|---|---|
| Sterilants Market Value (2023) | US$ 2361.627 million |
| Sterilants Market Expected Value (2033) | US$ 4244.1 million |
| Sterilants Market Projected CAGR (2023 to 2033) | 6% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Sterilization is an essential step to be carried out by laboratories and industries to avoid contamination and incidence of microbial transmission in aseptic areas. Sterilizing heat-sensitive instruments and surgical equipment that are highly susceptible to high temperatures can damage the instrument due to high temperatures or chemical reactions between the chemical sterilants and the instrument.
Thus, to avoid damage and the occurrence of chemical reactions, the demand for cold sterilants that are compatible and effective with low toxicity factors has increased. Consequently, the demand for sterilants is growing steadily owing to their strength and efficacy as compared to disinfectants.
According to FMI’s analysis, sterilants sales may grow from 2240.4 million in 2022 at a 19.7% CAGR between 2017 and 2022. The pandemic has strengthened the sales of sterilants and high-level disinfectants. Government initiatives to create awareness among people about hygienic environments are another factor expected to drive the sterilants market.
| Historical CAGR | 5.3% |
|---|---|
| Historical Market Value (2022) | US$ 2240.4 million |
| orecast CAGR | 6% |
The rising incidence of healthcare-associated infections due to the cross-contamination of surgical instruments or equipment along with the growing preference for an aseptic environment is expected to propel the sterilants market in the coming years.
Rising demand for cold sterilants to avoid damage to heat-sensitive instruments is also likely to drive market growth. Manufacturers have increased their focus on research and development efforts to launch new and effective formulations to leverage market growth. Moreover, government initiatives to support hygiene solutions are expected to boost the sterilants market growth during the forecast period.
Due to the pandemic, the rising demand for hygienic environments to avoid unnecessary exposure to infectious diseases or viruses in hospitals and clinics has driven the global demand for sterilants around the world. Government decisions to combat viral exposure have raised the approval rates for new products in the market.
For instance, in September 2020, EcoClear Products, Inc. received Environmental Protection Agency (EPA) approval for SteriCide™, a multi-use disinfectant, for use against emerging viral pathogens, including SARS-CoV-2 (COVID-19). EcoClear Products, Inc. is a leading cleaning solution and pest control company in the United States. Moreover, in April 2020, Solvay SA received EPA approval for PROXITANE® AHC for use against SARS-CoV-2 – the virus strain.
Principal Consultant
Regulatory complexity is the major factor expected to hamper the market growth. The utilization of high-level disinfectants or sterilants should be within the legal concentration range. For example, glutaraldehyde is normally used in the concentration range of 2 to 3%, but due to its high toxicity, the United States Environmental Protection Agency has limited its use.
Further, being a toxic chemical, the disposal of sterilants is another big challenge, as they are harmful to the environment. Numerous legal regulations implied by the Occupational Safety and Health Administration (OSHA) on waste disposal of disinfectants are forcing Forms to decrease the consumption of these chemicals. Due to the health and environmental hazards associated with chemical sterilants, numerous alternatives have been adopted by market players, which is expected to hamper the global sterilants market’s growth in the coming years.
Moreover, direct contact of high concentrations of sterilants with the skin is corrosive. According to the National Institute for Occupational Safety and Health, acute or chronic exposure to various sterilants may cause cancer, adverse reproductive effects, respiratory irritation, headaches, nausea, shortness of breath, mutagenic changes, neurotoxicity, sensitization, and many other adverse effects.
Increasing market consolidation activities including strategic acquisitions and collaborations between local players and the leading key players are a key trend impacting the sterilants market. The growing demand for low-temperature sterilization over steam sterilization is an emerging trend in the global sterilants market.
As all medical and scientific equipment is not able to resist the high temperature and humidity of the steam sterilization method, a suitable low-temperature sterilization method is required in the industrial sterilization field.
Several medical device companies are adopting low-temperature oxidative sterilization technology. This is based on two of these low-temperature oxidative methods, including peracetic acid gas/plasma technology and hydrogen peroxide plasma sterilization, developed by Advanced Sterilization Products (ASP).
The leading pharmaceutical players in the global market are adopting outsourcing models to expand their market footprint and thus generate a high rate of interest in the global sterilants market. Strategic long-term agreements and partnerships with local suppliers help manufacturers lower their operational costs. Furthermore, sterilants manufacturer companies can benefit from better pricing by outsourcing.
Overall run time and transportation and logistics costs are reduced to a great extent, which may benefit the key players in gaining a high revenue share in the market. For instance, In June 2018, Cantel Medical Corporation acquired Stericyle Inc.'s Controlled Environmental Solutions business, a leading provider of testing and certification, environmental monitoring, and decontamination services for cleanrooms and other controlled environments to ensure safety, regulatory compliance, and quality control.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The pharmaceutical & biotechnology industries have more emphasis on the maintenance of proper hygiene and providing an anti-bacterial environment in the manufacturing plant. Stringent regulations are followed by manufacturing plants focusing on the maintenance of hygiene and workplace safety, as even minor contamination during product manufacturing can lead to hazardous health issues.
In the United States, investments in research and development in the pharmaceutical sector have continuously increased in recent years and constitute over 40% of the global research and development investment in the pharmaceutical industry. Therefore, it is expected that the demand for sterilants will increase along with the growth of the pharmaceutical and biotechnology industries during the forecast period.
The growing healthcare sector also offers lucrative opportunities for manufacturers in the sterilants market. Governmental guidelines defined under the Affordable Care Act force hospital authorities to maintain cleanliness and hygiene services.
According to a Centers for Disease Control and Prevention (CDC) report, one out of 20 patients acquires an infection during a hospital visit in the United States. 75,000 people died due to such infections in 2014. Therefore, hospitals and consumers are increasingly adopting sterilants and disinfectants to reduce contamination and infection in hospitals.
Thus, infection control actions are expected to drive the market of sterilants during the forecast period. Furthermore, increased research and development efforts by manufacturers and researchers to develop novel and effective aseptic solutions and expansion of their product portfolio are expected to lead to lucrative opportunities in the competitive sterilants market.
Ethylene oxide (EO) sterilants are the most common industrial sterilants used for medical device sterilization. It is used in a ‘cold’ sterilization technique and offers high compatibility with most materials used in the manufacture of medical devices, such as plastics, polymers, metals, and glass.
Its lethality is driven by a chemical reaction (alkylation) with the DNA of bacteria, viruses, molds, yeasts, and even insects. Thus, owing to its advantage and compatibility ethylene oxide has the highest revenue share of US$ 605.31 million in 2023 and is expected to rise to annual revenue of US$ 995.42 million by 2033 with a 5.1% CAGR between 2023 and 2033.
The liquid sterilant form accounted for the highest share among the other forms owing to its compatibility with thermolabile products.
The hospital’s segment accounted for the highest share of the sterilants market with a CAGR of 4.5%. The overall demand for sterilants in hospitals is largely driven by the increasing prevalence of human-associated infections (HAIs), the growing number of surgical procedures, and the increasing number of hospitals worldwide.
The rising geriatric population is one of the key contributors to the sterilants market growth for hospitals. As the geriatric population is more susceptible to chronic diseases.
| Region | North America |
|---|---|
| Country | United States |
| Historic CAGR | 18.9% |
| Forecasted CAGR | 5.2% |
| Absolute Dollar Growth | US$ 30.6 million |
| Market Value (2033) | US$ 1095.4 million |
| Region | North America |
|---|---|
| Country | Canada |
| Historic CAGR | 16.9% |
| Forecasted CAGR | 3.2% |
| Absolute Dollar Growth | US$ 2.50 million |
| Market Value (2033) | US$ 119.1 million |
| Region | Europe |
|---|---|
| Country | Germany |
| Historic CAGR | 18.2% |
| Forecasted CAGR | 1.8% |
| Absolute Dollar Growth | US$ 6.4 million |
| Market Value (2033) | US$ 187.8 million |
| Region | Europe |
|---|---|
| Country | United Kingdom |
| Historic CAGR | 3.4 % |
| Forecasted CAGR | 3.9 % |
| Absolute Dollar Growth | US$ 0.2 million |
| Market Value (2033) | US$ 7 million |
| Region | Asia Pacific |
|---|---|
| Country | China |
| Historic CAGR | 19.0% |
| Forecasted CAGR | 6.3% |
| Absolute Dollar Growth | US$ 10.3 million |
| Market Value (2033) | US$ 333.6 million |
In the United States, the healthcare system is well known for its high expenses and well-developed infrastructure. The United States government and regulatory bodies are implementing various cost-effective plans to reduce their healthcare burden. Moreover, the heavy consumption of sterilants in the country, pushed by the high demand for sterility and hygiene maintenance due to the pandemic and to avoid infection exposure, the country has witnessed a huge growth rate over the past few months.
The country experienced the toughest hit of the infection, with a large number of cases diagnosed and the highest proportionate death rate recorded globally. As a result, Americans spent liberally on sterility measures, which resulted in growth in consumption of the same. Furthermore, the presence of leading players like 3M Company, Steris Plc., Cantel Medical Corporation, Thor Group, and many others in the region also helped drive the market in the region.
Increasing disposable income could project a significant impact on economic development in emerging countries which results in the affordability of proper healthcare treatment. China’s per capita disposable income reached about US$ 4,961 in 2020, which doubled the level in 2010.
The potential for rising disposable income with high healthcare insurance is expected to contribute to increasing the affordability of healthcare services intended to prevent infectious diseases. The market in China is expected to witness significant growth at a CAGR of around 6.3%.
The strong emergence of biopharmaceutical and pharmaceutical companies with growing research efforts is expected to offer opportunities in the sterilants market. However, India has the highest consumption of sterilants as compared to other South Asian countries. Sterilization demand is expected to increase, as most products in the pipeline are likely to reach the end stage and be commercialized by the end of the decade.
In developing countries, it is easier to recruit patients for clinical trials. Research and development costs in India are substantially less compared to those in developed countries, and it is possible to innovate and develop effective products at competitive rates. India accounted for more than 45% of the South Asia sterilants market.
Recent Development
Many leading players are focusing on various market consolidation activities such as mergers, acquisitions, supply distribution partnerships, and launching new products, leading to high competitiveness in the market. Key manufacturers are keen to expand the market footprint of their key products and provide solutions to end users. For instance, many leading manufacturers nowadays provide customized solutions based on various end-user requirements.
Thus, the ongoing innovative product offerings by market players can maintain supply and demand, assisting the overall market growth during the forecast period.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | US$ million for Value and MT for Volume |
| Key Regions Covered | North America; Latin America; Europe; The Middle East and Africa; East Asia |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Chile, Peru, Germany, UNITED KINGDOM, Spain, Italy, France, Russia, Poland, China, India, Japan, Australia, New Zealand, GCC Countries, North Africa, South Africa, and Turkey |
| Key Segments Covered | Product, Form, End User, Region |
| Key Companies Profiled | 3M Company; Steris Plc.; Cantel Medical Corporation; Evonik Industries AG; Arkema S.A.; Thor Group; Metrex Research, LLC; Ecolab Inc.; Solvay SA; LANXESS; Contec, Inc.; OZU Corporation; Cetylite, Inc.; Veltek Associates, Inc.; Whiteley Corporation; Gul Biyoloji Laboratuvari |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
During 2017 to 2022, the market recorded a CAGR of 5.3%.
Consumers seek preservative-free, natural processed foods raising the market growth.
The increasing demand for heat-sensitive medical devices and supplies is the top trend.
The United States is dominating the industry.
The market is likely to surpass US$ 4244.1 million by 2033.
1. Executive Summary | Sterilants Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033 5.3.1. Ethylene Oxide 5.3.2. Glutaraldehyde 5.3.3. Hydrogen Peroxide Gas Plasma 5.3.4. Vaporized Hydrogen Peroxide 5.3.5. Immersion and Vapour Phase Peracetic Acid 5.3.6. Others 5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Form 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Form, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Form, 2023 to 2033 6.3.1. Liquid 6.3.2. Spray 6.4. Y-o-Y Growth Trend Analysis By Form, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Form, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-user 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End-user , 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-user , 2023 to 2033 7.3.1. Hospitals 7.3.2. Clinics 7.3.3. Ambulatory Surgical Centres 7.3.4. Rehabilitation Centres 7.3.5. Diagnostic Laboratories 7.3.6. Pharmaceutical & Biotechnology Companies 7.3.7. Academics and Research Institutes 7.4. Y-o-Y Growth Trend Analysis By End-user , 2018 to 2022 7.5. Absolute $ Opportunity Analysis By End-user , 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. South Asia 8.3.5. East Asia 8.3.6. Oceania 8.3.7. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Product 9.2.3. By Form 9.2.4. By End-user 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product 9.3.3. By Form 9.3.4. By End-user 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product 10.2.3. By Form 10.2.4. By End-user 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By Form 10.3.4. By End-user 10.4. Key Takeaways 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. United Kingdom 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Product 11.2.3. By Form 11.2.4. By End-user 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By Form 11.3.4. By End-user 11.4. Key Takeaways 12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Malaysia 12.2.1.3. Singapore 12.2.1.4. Thailand 12.2.1.5. Rest of South Asia 12.2.2. By Product 12.2.3. By Form 12.2.4. By End-user 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By Form 12.3.4. By End-user 12.4. Key Takeaways 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Product 13.2.3. By Form 13.2.4. By End-user 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By Form 13.3.4. By End-user 13.4. Key Takeaways 14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. Australia 14.2.1.2. New Zealand 14.2.2. By Product 14.2.3. By Form 14.2.4. By End-user 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By Form 14.3.4. By End-user 14.4. Key Takeaways 15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Product 15.2.3. By Form 15.2.4. By End-user 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product 15.3.3. By Form 15.3.4. By End-user 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Product 16.1.2.2. By Form 16.1.2.3. By End-user 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Product 16.2.2.2. By Form 16.2.2.3. By End-user 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Product 16.3.2.2. By Form 16.3.2.3. By End-user 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Product 16.4.2.2. By Form 16.4.2.3. By End-user 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Product 16.5.2.2. By Form 16.5.2.3. By End-user 16.6. United Kingdom 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Product 16.6.2.2. By Form 16.6.2.3. By End-user 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Product 16.7.2.2. By Form 16.7.2.3. By End-user 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Product 16.8.2.2. By Form 16.8.2.3. By End-user 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Product 16.9.2.2. By Form 16.9.2.3. By End-user 16.10. India 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Product 16.10.2.2. By Form 16.10.2.3. By End-user 16.11. Malaysia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Product 16.11.2.2. By Form 16.11.2.3. By End-user 16.12. Singapore 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Product 16.12.2.2. By Form 16.12.2.3. By End-user 16.13. Thailand 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Product 16.13.2.2. By Form 16.13.2.3. By End-user 16.14. China 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Product 16.14.2.2. By Form 16.14.2.3. By End-user 16.15. Japan 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Product 16.15.2.2. By Form 16.15.2.3. By End-user 16.16. South Korea 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Product 16.16.2.2. By Form 16.16.2.3. By End-user 16.17. Australia 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Product 16.17.2.2. By Form 16.17.2.3. By End-user 16.18. New Zealand 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Product 16.18.2.2. By Form 16.18.2.3. By End-user 16.19. GCC Countries 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Product 16.19.2.2. By Form 16.19.2.3. By End-user 16.20. South Africa 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Product 16.20.2.2. By Form 16.20.2.3. By End-user 16.21. Israel 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Product 16.21.2.2. By Form 16.21.2.3. By End-user 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product 17.3.3. By Form 17.3.4. By End-user 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. 3M Company 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Steris Plc. 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Cantel Medical Corporation 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Evonik Industries AG 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Arkema S.A. 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Thor Group 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Metrex Research, LLC 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Ecolab Inc. 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Solvay SA 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. LANXESS 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.11. Contec, Inc. 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.12. OZU Corporation 18.1.12.1. Overview 18.1.12.2. Product Portfolio 18.1.12.3. Profitability by Market Segments 18.1.12.4. Sales Footprint 18.1.12.5. Strategy Overview 18.1.12.5.1. Marketing Strategy 18.1.13. Cetylite, Inc. 18.1.13.1. Overview 18.1.13.2. Product Portfolio 18.1.13.3. Profitability by Market Segments 18.1.13.4. Sales Footprint 18.1.13.5. Strategy Overview 18.1.13.5.1. Marketing Strategy 18.1.14. Veltek Associates, Inc. 18.1.14.1. Overview 18.1.14.2. Product Portfolio 18.1.14.3. Profitability by Market Segments 18.1.14.4. Sales Footprint 18.1.14.5. Strategy Overview 18.1.14.5.1. Marketing Strategy 18.1.15. Whiteley Corporation 18.1.15.1. Overview 18.1.15.2. Product Portfolio 18.1.15.3. Profitability by Market Segments 18.1.15.4. Sales Footprint 18.1.15.5. Strategy Overview 18.1.15.5.1. Marketing Strategy 18.1.16. Gul Biyoloji Laboratuvari 18.1.16.1. Overview 18.1.16.2. Product Portfolio 18.1.16.3. Profitability by Market Segments 18.1.16.4. Sales Footprint 18.1.16.5. Strategy Overview 18.1.16.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Sterilants Market
